ERIS Lifesciences Ltd | Industry : (Pharmaceuticals) | |
---|---|---|
|
|
|
|
|
|
|
|
|
Mar '2024 | Mar '2023 | Mar '2022 | Mar '2021 | Mar '2020 | |
---|---|---|---|---|---|
SOURCES OF FUNDS : | |||||
Equity Share Capital | 13.60 | 13.60 | 13.59 | 13.58 | 13.58 |
Reserves | 2,510.42 | 2,208.29 | 1,904.51 | 1,561.89 | 1,286.12 |
Equity Share Warrants | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Equity Application Money | 0.00 | 0.00 | 0.45 | 0.00 | 0.00 |
Total Shareholders Funds | 2,524.02 | 2,221.89 | 1,918.55 | 1,575.47 | 1,299.70 |
Secured Loans | 1,457.84 | 316.87 | 0.00 | 0.00 | 0.00 |
Unsecured Loans | 1,071.61 | 0.00 | 0.00 | 0.00 | 0.00 |
Total Debt | 2,529.45 | 316.87 | 0.00 | 0.00 | 0.00 |
Other Liabilities | 77.83 | 68.53 | 65.62 | 34.88 | 33.99 |
Total Liabilities | 5,131.30 | 2,607.29 | 1,984.17 | 1,610.35 | 1,333.69 |
APPLICATION OF FUNDS : | |||||
Gross Block | 1,811.19 | 1,094.83 | 778.40 | 716.88 | 695.65 |
Less: Accumulated Depreciation | 295.64 | 197.02 | 136.40 | 132.55 | 95.01 |
Less:Impairment of Assets | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Block | 1,515.55 | 897.81 | 642.00 | 584.33 | 600.64 |
Lease Adjustments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Capital Work in Progress | 0.61 | 0.34 | 2.98 | 1.56 | 4.37 |
Investments | 1,618.95 | 996.52 | 777.72 | 531.37 | 320.30 |
Current Assets, Loans & Advances | |||||
Inventories | 91.64 | 63.70 | 84.79 | 64.85 | 65.46 |
Sundry Debtors | 239.97 | 229.22 | 137.56 | 113.76 | 140.82 |
Cash and Bank Balance | 1,296.74 | 47.65 | 46.11 | 32.66 | 64.95 |
Loans and Advances | 248.21 | 181.50 | 212.02 | 161.98 | 104.09 |
Total Current Assets | 1,876.55 | 522.07 | 480.47 | 373.24 | 375.32 |
Less : Current Liabilities and Provisions | |||||
Current Liabilities | 175.58 | 114.10 | 123.38 | 110.08 | 114.34 |
Provisions | 42.68 | 62.27 | 42.86 | 34.38 | 35.10 |
Total CL & Provisions | 218.27 | 176.37 | 166.24 | 144.46 | 149.44 |
Net Current Assets | 1,658.29 | 345.70 | 314.23 | 228.78 | 225.89 |
Miscellaneous Expenses not written off | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Deferred Tax Assets | 485.08 | 399.14 | 350.70 | 297.27 | 240.62 |
Deferred Tax Liability | 181.30 | 125.36 | 114.59 | 100.52 | 76.46 |
Net Deferred Tax | 303.78 | 273.78 | 236.11 | 196.75 | 164.16 |
Other Assets | 34.12 | 93.13 | 11.14 | 67.58 | 18.33 |
Total Assets | 5,131.31 | 2,607.29 | 1,984.19 | 1,610.36 | 1,333.69 |
Contingent Liabilities | 332.46 | 630.39 | 24.34 | 18.32 | 15.81 |